Showing items 1 - 2 of 2

Your selections:

Phase 2 study of anastrozole in rare cohorts of patients with estrogen receptor/progesterone receptor positive leiomyosarcomas and carcinosarcomas of the uterine corpus: The PARAGON trial (ANZGOG 0903)

- Edmondson, R. J., O'Connell, R. L., Benson, C., Hamilton, A., Sjoquist, K., Alexander, L., Kelly, C., Carty, K., Divers, L., Bradshaw, N., Friedlander, M., Banerjee, S., Mileshkin, L., Sykes, P., Beale, P., Fisher, A., Bonaventura, A., Millan, D., Nottley, S.

Knowledge of risk management strategies, and information and risk management preferences of women at increased risk for ovarian cancer

- Tiller, K., Meiser, B., Gould, L., Tucker, K., Dudding, Tracy, Franklin, J., Friedlander, M., Andrews, L.

  • 1
  • Disclaimer
  • Privacy
  • Copyright
  • Contact
  • Deposit